Why Edibles Hit Differently: The 11-Hydroxy-THC Explanation

When you smoke or vape cannabis, the process acts as a shortcut to the brain. Inhalation allows cannabinoids to bypass the digestive tract, reaching the bloodstream almost instantly. Edibles, however, take a different route. They undergo what is known as first-pass metabolism, a biological filter that alters the chemistry of the experience.

By Harrison

If you have ever wondered why an edible feels different from a joint, the answer lies in your liver.

The Hepatic Shift: From Delta-9 to 11-Hydroxy-THC

When you eat a cannabis-infused product, it travels through your stomach and small intestine before heading to the liver via the portal vein. Here, your liver performs its primary job: processing substances to make them easier to excrete.

Your liver uses an enzyme called CYP2C9 to break down Delta-9-THC. During this process, a hydroxyl group is added to the molecule, turning it into 11-Hydroxy-THC (11-OH-THC).

This metabolite is a powerful compound. 11-OH-THC exhibits a higher affinity for the blood-brain barrier than Delta-9-THC. Once it crosses into the brain, it remains there for an extended period, which may explain why the edible experience often feels more intense, lasts longer, and has a sedative quality that smoking often lacks.

How Your Receptors React

The Endocannabinoid System (ECS) is your body’s internal control panel, using two primary receptors—CB1 and CB2—to manage physiological responses.

CB1: The "Head" Experience

CB1 receptors are clustered in your central nervous system, particularly in the cerebellum and hippocampus. When 11-OH-THC binds here, it influences the release of neurotransmitters like glutamate and GABA. By modulating the signaling in your brain, you may experience the euphoria, sensory shifts, and altered perception associated with edibles.

CB2: The "Body" Sensation

CB2 receptors are spread throughout your immune system and peripheral tissues. Because edibles circulate through your blood for an extended period, they provide a steady, systemic interaction with these receptors. This is why many people use edibles to support the management of chronic inflammation or muscle tension—they provide a sustained effect that reaches the whole body.

Bioavailability: Why Fats Matter

Cannabinoids are lipophilic, meaning they bind to fat. If you consume a gummy on an empty stomach without any fat to help transport the cannabinoids, much of the dose may not be absorbed effectively.

  • MCT Oil: This is often used for infusions. Because MCTs (medium-chain triglycerides) are processed rapidly by the liver, they may act as an efficient delivery system for THC, supporting its conversion into 11-OH-THC.
  • Sunflower Lecithin: This acts as a bridge between oil and water. It functions as a surfactant, breaking the cannabis oil into tiny droplets called micelles. This increases the surface area for your digestive enzymes, which may lead to a more consistent absorption rate.

The Pharmacokinetic Clock

Expectations dictate experience. When you ingest an edible, your body follows a predictable schedule:

advertisement
  • 0–45 Minutes: The "Prep Phase." Your stomach is breaking down the material. You likely will not feel any effects yet.
  • 45–120 Minutes: The "Conversion Phase." Your liver is actively creating 11-OH-THC. Plasma levels start to rise.
  • 2–4 Hours: The "Peak." You are often at maximum 11-OH-THC concentration in the brain.
  • 4–8 Hours: The "Decline." Your body continues to process and eventually eliminate the metabolites.

Why Your Friend’s Dose Might Not Work for You

Biology is not one-size-fits-all. Your genetic makeup—specifically your CYP2C9 gene—determines how fast you process these compounds.

  • Fast Metabolizers: These individuals have high enzymatic activity. They might clear the THC so quickly that they feel little to nothing, even from a high dose.
  • Slow Metabolizers: If you lack efficient CYP2C9 activity, THC may linger in your system, potentially leading to a much stronger experience.

It is worth noting that everyone has a different density of CB1 receptors. Even with the same amount of 11-OH-THC in your blood, two people will have entirely different experiences based on how many receptors their brain has available for the cannabinoids to bind to.

The Role of Terpenes

You cannot discuss cannabinoids without mentioning terpenes. These compounds shape the profile of the experience. Myrcene, for example, is thought to support the movement of cannabinoids across the blood-brain barrier, potentially shortening the wait time for an edible to take effect. Limonene is often used to balance the experience, potentially smoothing out the tension that can sometimes accompany high-dose THC. By understanding these interactions, you gain more insight into the potential outcome.


Legal Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Always seek the advice of a physician regarding a medical condition. Efficacy has not been confirmed by FDA-approved research. Check your local laws regarding cannabis and terpene use.

Sources

  1. Huestis MA. (2007). Human cannabinoid pharmacokinetics. Chem Biodivers. 4(8):1770-804. PubMed

  2. Grotenhermen F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 42(4):327-60. PubMed

  3. Lemberger L, Martz R, Rodda B, Forney R, Rowe H. (1973). Comparative pharmacology of Delta-9-tetrahydrocannabinol and its metabolite, 11-OH-Delta-9-tetrahydrocannabinol. J Clin Invest. 52(10):2411-17. PubMed

  4. Russo EB. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 163(7):1344-64. PubMed

advertisement

Ready to find your strain?

Add your strains, pick your effects — we'll rank them.

Open Matchleaf →